Riskpilot← Back to searchSign inGet full accessSTERK HELSE AS
ASActiveOrg 923215891Bøkkerveien 4, 0579 OsloGeneral medical practice activities · NACE 8621Est. 20198 employees
Revenue 2024
NOK 8,8M
+21% vs 2023
EBITDA margin
16.4%
+220% vs 2023
Equity ratio
12.8%
Financial strength
Net profit 2024
NOK 970K
+493% vs 2023
| Revenue | NOK 8,8M | +21% |
| EBITDA | NOK 1,5M | +220% |
| Net profit | NOK 970K | +493% |
| Total assets | NOK 4,8M | +46% |
| Equity | NOK 617K | +246% |
| Employees | 8 | — |
Legal name
STERK HELSE AS
Org number
923215891
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
21. august 2019
Share capital
NOK 99 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Drive legesenter og fysikalsk institutt, samt andre helserelaterte tjenester.
Address
Bøkkerveien 4, 0579 Oslo
Phone
+4721012800
Email
trening@sterkhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 13 722 | 9 527 | 7 348 | 7 299 | 8 842 |
| Staff expenses | −3 910 | −4 157 | −3 411 | −1 817 | −1 654 |
| EBITDA | 1 640 | −246 | −333 | 455 | 1 453 |
| Depreciation & amort. | −32 | −77 | −97 | −102 | −106 |
| EBIT | 1 609 | −323 | −430 | 352 | 1 348 |
| Net financials | −69 | −30 | −95 | −143 | −104 |
| Profit before tax | 1 540 | −353 | −526 | 210 | 1 244 |
| Tax | 170 | −77 | −115 | 46 | 274 |
| Net profit | 1 370 | −276 | −411 | 164 | 970 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 865 | 2 672 | 3 641 | 3 319 | 4 835 |
| Equity | 701 | 426 | 15 | 178 | 617 |
| Long-term debt | 4 | 0 | 1 292 | 1 292 | 1 292 |
| Short-term debt | 3 159 | 2 246 | 2 335 | 1 849 | 2 926 |
| Total debt | 3 163 | 2 246 | 3 626 | 3 141 | 4 218 |
EBITDA margin
16.4%
This company
15.8%
Market median
+4% vs market
20202024
Equity ratio
12.8%
This company
38.2%
Market median
-66% vs market
20202024
Return on equity
157.2%
This company
18.4%
Market median
+754% vs market
20202024
Net profit margin
11.0%
This company
8.1%
Market median
+36% vs market
20202024
Asset turnover
1.83×
This company
1.12×
Market median
+63% vs market
20202024
Debt / equity
6.83×
This company
0.62×
Market median
-1002% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KL Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Daniel Strengelsrud Holding As
STERK HELSE AS Board members of STERK HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjetil Larsen | Chief Executive Officer | 0 companies |
| Daniel Fernandez Strengelsrud | Chairman | 0 companies |